Results 181 to 190 of about 2,285,924 (374)

Granulocyte colony-stimulating factor and erythropoietin for the anemia of myelodysplastic syndromes: a real improvement with respect to erythropoietin alone? [letter; comment] [PDF]

, 1994
P. Musto, Antonietta Falcone, M Carotenuto, Lucio Catalano, A Cennamo, Bruno Rotoli   +5 more
openalex   +1 more source

Homoharringtonine Promotes FTO Degradation to Suppress LILRB4‐Mediated Immune Evasion in Acute Monocytic Leukaemia

Cell Proliferation, EarlyView.
Homoharringtonine (HHT) suppresses immune evasion in acute monocytic leukaemia (AML‐M5) by attenuating the FTO/m6A/LILRB4 axis, thereby enhancing CD8+ T cell cytotoxicity. ABSTRACT Acute monocytic leukaemia, a subtype of acute myeloid leukaemia (AML), is a highly aggressive malignancy characterised by a poor prognosis, primarily due to the ability of ...
Fangfang Huang, Xiang Luo, Mengyu Zhang, Le Jin, Wenxin Sun, Peihan Chen, Xiuli Hong, Chenyu Xu, Meizhi Jiang, Die Hu, Bin Zhang, Shengwei Hu, Chuanjiang Yang, Rui Gao, Jinzhang Zeng, Quanyi Lu, Qiang Luo, Jun Wu, Siming Chen   +18 more
wiley   +1 more source

Repurposing colchicine for reduction of residual inflammatory risk in type 1 diabetes: Design and rationale of the REC1TE trial

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Compared to people without diabetes, individuals with type 1 diabetes have a several‐fold increased risk of cardiovascular (CV) morbidity and mortality despite guideline‐recommended management of traditional risk factors; so‐called residual CV risk.
David S. Mathiesen, Josefine V. Hansen, Aske Høck, Casper K. Nielsen, Miriam G. Pedersen, Peter L. Kristensen, Henrik U. Andersen, Marie Louise Aarestrup, Julie L. Forman, Jonatan I. Bagger, Thomas F. Dejgaard, Filip K. Knop, Nicklas J. Johansen, Asger B. Lund   +13 more
wiley   +1 more source

Myelodysplastic syndromes. A multiparametric study of prognostic factors in 336 patients

, 1987
Bertrand Coiffier, Patrice Adeleine, O Gentilhomme, Pascale Felman, Danielle Treille-Ritouet, Paul‐André Bryon   +5 more
openalex   +1 more source

Treatment of myelodysplastic syndromes with all-trans retinoic acid. Leukemia Study Group of the Ministry of Health and Welfare [PDF]

, 1993
R Ohno, T Naoe, M Hirano, Miki Kobayashi, Hisamaru Hirai, Kazuo Tubaki, H Oh   +6 more
openalex   +1 more source

HASH(0x563d44119a08) [PDF]

, 2009
HASH(0x563d44067a70)HASH ...
Nachtnebel, A.
core  

Primary CD34+ cells of patients with vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic (VEXAS) syndrome are highly sensitive to targeted treatment with TAK‐243

British Journal of Haematology, EarlyView.
Daniel Nowak, Marie Demmerle, Alessa Klär, Alexander Streuer, Vladimir Riabov, Eva Altrock, Felicitas Rapp, Ann‐Christin Belzer, Teresa Klink, Meret Hahn, Franziska Hofmann, Verena Nowak, Nadine Weimer, Julia Obländer, Iris Palme, Melda Göl, Ali Darwich, Laurenz Steiner, Mohammed Abba, Georgia Metzgeroth, Wolf‐Karsten Hofmann, Nanni Schmitt   +21 more
wiley   +1 more source

Role of remdesivir for the treatment of COVID‐19 in patients with hematologic malignancy—A narrative review and expert opinion

European Journal of Clinical Investigation, EarlyView.
Created in BioRender. Ghezzi, S. (2025) https://BioRender.com/q1lticg. Abstract Background COVID‐19 remains a potentially severe condition for immunocompromised individuals, such as patients with hematologic malignancy. These patients are at increased risk of progressing to severe–critical or prolonged COVID‐19.
Malgorzata Mikulska, Matteo Bassetti, Alessandro Busca, Valeria Cento, Maddalena Giannella, Michele Bartoletti   +5 more
wiley   +1 more source

Patients’ needs in hematology: whose perspectives?

Haematologica, 2013
Sam Salek, Tatyana Ionova, Esther Oliva
doaj   +1 more source

Bone marrow histology. 3: Value of bone marrow core biopsy in acute leukaemia, myelodysplastic syndromes, and chronic myeloid leukaemia. [PDF]

, 1992
D.A. Winfield, S V Polacarz
openalex   +1 more source